Coherus Announces CFO Transition Plans
REDWOOD CITY, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) announced that Chief...
Day: February 16, 2021
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
HST-001 Found to be Safe and Well Tolerated with No Serious Adverse Events Planning Underway for Next Clinical Study in...
Recce Pharmaceuticals Announces Agreement with Fiona Stanley Hospital for a Phase 1/2 Clinical Trial Evaluating Topical Spray-On Antibiotic RECCE® 327 on Chronic Burn Wounds
Highlights: Phase I/II trial agreement with Fiona Stanley Hospital (Burns Unit) in Perth Western AustraliaStudy led by world leading burn...
Assure Holdings Form S-1 Registration Statement Declared Effective
DENVER, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH) announces that...
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults
VivoScore Opens the Door for More Patients to be Diagnosed and Treated for Sleep ApneaHIGHLANDS RANCH, Colo., Feb. 16, 2021...
Recce Pharmaceuticals Announces Encouraging Results from Anti-viral Screening Program at The Doherty Institute Evaluating RECCE® 327 Against SARS-CoV-2
RECCE® 327 RT-PCR and Cell Viability Data RECCE® 327 RT-PCR and Cell Viability Data Highlights: RECCE® 327, a synthetic anti-infective...
Selecta Biosciences to Present at the SVB Leerink 10th Annual Global Healthcare Conference
WATERTOWN, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™...
Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
Utilizing HealthTab™ and rapid-antigen tests at resort locations to screen for the virus prior to return, with validation from Avrok...
GBS Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
- December 2020 Initial Public Offering generated $21.6m in gross proceeds andlisting on the NASDAQ Stock Market -Executes Partnerships, Research...
Oncology Pharma is Pleased to Welcome New Chairman to Its Scientific Advisory Board
SAN FRANCISCO, CA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to...
Extendicare Announces February 2021 Dividend of C$0.04 per Share
MARKHAM, Ontario, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Immunovant Reports Financial Results for the Quarter and Nine Months Ended December 31, 2020
Company Ended the Quarter With Cash of Approximately $422 MillionNEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq:...
Sotera Health to Present at Upcoming Healthcare Conferences
CLEVELAND, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization...
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
No Dose Limiting Toxicities or Serious Adverse Events Observed in Dosing Regimen Previously Untested in Clinical Trial SettingCHARLOTTESVILLE, Va., Feb....
PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections
Top-line Data Anticipated by Year End 2021 Enrollment Also Continues to Progress in Company’s Second Phase 3 Clinical Trial, SHIELD...
Evaxion Biotech Opens New Office and Laboratories to Support Future Growth
COPENHAGEN, Denmark, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX), a clinical-stage biotechnology company specializing in the...
BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales
CRESSKILL, N.J. and JERUSALEM, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...
Monopar Announces First Patient Dosed in its Phase 2b/3 VOICE Trial Evaluating Validive® for the Prevention of Chemoradiotherapy-Induced Severe Oral Mucositis (SOM) in Oropharyngeal Cancer (OPC)
There are currently no FDA-approved drugs to prevent or treat chemoradiotherapy-induced SOMWILMETTE, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Monopar...
OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing
Study highlights best practice techniques for accurate antimicrobial resistance prediction from whole-genome sequencing data Publication supports harmonization of the development...
Salarius Pharmaceuticals to Present at BIO CEO & Investor Digital Conference
HOUSTON, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing potential new medicines for patients...